- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7233
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
WNT5A as a therapeutic target in breast cancer ; day:31 ; month:8 ; year:2018 ; pages:1-12
Cancer and metastasis reviews ; (31.8.2018), 1-12
- Creator
-
Prasad, Chandra Prakash
- Contributor
-
Manchanda, Mansi
Mohapatra, Purusottam
Andersson, Tommy
SpringerLink (Online service)
- DOI
-
10.1007/s10555-018-9760-y
- URN
-
urn:nbn:de:101:1-2018102112373870574127
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Prasad, Chandra Prakash
- Manchanda, Mansi
- Mohapatra, Purusottam
- Andersson, Tommy
- SpringerLink (Online service)
Other Objects (12)
Possible therapeutic targets for NLRP3 inflammasome-induced breast cancer
Mitotic kinases are emerging therapeutic targets against metastatic breast cancer
Osteopontin is a therapeutic target that drives breast cancer recurrence
KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges
Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer
Ubiquitin-specific proteases as therapeutic targets for the treatment of breast cancer
ATP synthase ecto-α-subunit: a novel therapeutic target for breast cancer
Identification of PADI2 as a potential breast cancer biomarker and therapeutic target
Tumor microenvironment: driving forces and potential therapeutic targets for breast cancer metastasis
SHP2 is a multifunctional therapeutic target in drug resistant metastatic breast cancer
Lysine lactylation (Kla) might be a novel therapeutic target for breast cancer
Possible therapeutic targets for NLRP3 inflammasome-induced breast cancer
Mitotic kinases are emerging therapeutic targets against metastatic breast cancer
Osteopontin is a therapeutic target that drives breast cancer recurrence
KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges
Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer
Ubiquitin-specific proteases as therapeutic targets for the treatment of breast cancer
ATP synthase ecto-α-subunit: a novel therapeutic target for breast cancer
Identification of PADI2 as a potential breast cancer biomarker and therapeutic target
Tumor microenvironment: driving forces and potential therapeutic targets for breast cancer metastasis
SHP2 is a multifunctional therapeutic target in drug resistant metastatic breast cancer
Lysine lactylation (Kla) might be a novel therapeutic target for breast cancer
Possible therapeutic targets for NLRP3 inflammasome-induced breast cancer
Mitotic kinases are emerging therapeutic targets against metastatic breast cancer
Osteopontin is a therapeutic target that drives breast cancer recurrence
KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges
Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer
Ubiquitin-specific proteases as therapeutic targets for the treatment of breast cancer
ATP synthase ecto-α-subunit: a novel therapeutic target for breast cancer
Identification of PADI2 as a potential breast cancer biomarker and therapeutic target
Tumor microenvironment: driving forces and potential therapeutic targets for breast cancer metastasis
SHP2 is a multifunctional therapeutic target in drug resistant metastatic breast cancer